论文信息 - O-14 Exploratory biomarker analysis of trastuzumab deruxtecan in DESTINY-Gastric01, a randomized, phase 2, multicenter, open-label study in patients with HER2-positive or -low advanced gastric or gastroesophageal junction adenocarcinoma - 字舞流文

O-14 Exploratory biomarker analysis of trastuzumab deruxtecan in DESTINY-Gastric01, a randomized, phase 2, multicenter, open-label study in patients with HER2-positive or -low advanced gastric or gastroesophageal junction adenocarcinoma

N. Sugimoto | D. Sakai | M. Ryu | K. Inaki | H. Chung | Y. Omuro | S. Iwasa | T. Nishina | Y. Bang | K. Shitara | K. Yamaguchi | H. Kawakami | M. Sugihara | H. Yabusaki | A. Kojima | Y. Sakamoto | F. Suto | K. Saito | Yusuke Kuwahara